-
Stock market update: Sensex, Nifty hit day’s low; breadth positive
The market breadth was positive. On the BSE, 1431 shares rose and 1185 shares fell. A total of 147 shares were unchanged.
Money9May 12, 2021/11:04 AM IST -
Covid-19: India records 4,205 fatalities, 3.48 lakh new cases in the last 24 hours
The active cases have reduced to 37,04,099 comprising 15.87 % of the total infections, while the national COVID-19 recovery rate has improved to 83.04 %.
Press Trust of IndiaMay 12, 2021/10:34 AM IST -
Petrol goes past Rs 100-mark, diesel price hits fresh high; check rates in top cities
Petrol increased by 25 paise and diesel by 27 paise per litre today for third day in a row
Jaya RaiMay 12, 2021/10:15 AM IST -
Mutual fund rating preferred functionality for those doing own investments, says study
Post-COVID a large number of investors have gone digital and doing investments on their own, the survey found.
Money9May 12, 2021/9:53 AM IST -
Global cues drag Sensex down by 269 points; Nifty holds 14,800
Sensex slipped 269 points or 0.55% at 48,892 while the broader market index Nifty 50 was at 14,803 down by 47 points or 0.32%.
Money9May 12, 2021/9:19 AM IST -
Stocks to watch: Infosys, Dr. Reddy’s Laboratories, Godrej Consumer Products, Siemens, Linde India, Kalpataru Power Transmission
Trading of Nifty 50 index futures on the Singapore stock exchange indicates that the Nifty could fall 29 points at the opening bell. On the macro data front, investors are awaiting the industrial production and manufacturing production data for March, and inflation for April, scheduled to be released later in the day. Infosys: The company […]
Harsh ChauhanMay 12, 2021/8:50 AM IST -
Trading ideas: 8 stock recommendations for Wednesday
Here are 9 money making ideas from technical analysts that may deliver good gains in the near term
Rahul OberoiMay 12, 2021/8:48 AM IST -
SGX Nifty indicates opening with small losses for Sensex, Nifty
Asian peers trading lower as investors remain cautious over growing inflation worries.
Money9May 12, 2021/8:39 AM IST -
Bharat Biotech’s Covaxin recommended by expert panel for phase 2/3 trials on 2-18 year-olds
The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur
Press Trust of IndiaMay 12, 2021/8:18 AM IST
